Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207572262> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W3207572262 endingPage "S1359" @default.
- W3207572262 startingPage "S1359" @default.
- W3207572262 abstract "Comprehensive genomic profiling (CGP) by next-generation sequencing (NGS) is increasingly used as a pre-screening tool for clinical trials. The aim of this project was to retrospectively determine the scope of alterations identified by CGP that could render patients suitable for alternative early phase clinical trials of genomically-matched (GM) / immunotherapy (IO) or ‘off-label’ drug use. Patients were pre-screened for the STARTRK2 study (Roche sponsored study of Entrectinib, NCT02568267) at The Christie NHS foundation Trust using FoundationOneCDx. Testing is validated for NTRK, ROS1 and ALK fusion testing but all pathogenic alterations are reported on a clinical trial specific Foundation Medicine (FM) report. Results were scrutinised for actionable alterations that could direct patients to alternative clinical trials or off label drug use. A total of 269 patients with were consented since FM testing was introduced in the trial in Jan’2019. FM yielded results in 229 patients (85.2%), mean age was 54, 58.4% were male and 45.8% had 1-2 prior systemic lines. Most prevalent tumour subtypes were colorectal (26.4%), head and neck (21.6%) and sarcomas (7.1%). Most prevalent alterations occurred in: TP53 (12.6%), APC (8.4%) and KRAS (4.6%). MSI-High was 1.5%. No patients had NTRK/ROS1 fusions, 1 non-small cell lung cancer patient had ALK fusion. 104 (45.4%) patients were potentially eligible for matched clinical trials (101 for GM and 3 for IO) and 61 (26.6%) patients could have been considered for off-label drug use. The most prevalent actionable alterations found across common and rare disease types were PI3KCA (10%), ERBB2 (6.1%), PTEN (3.1%), tumour mutation burden ≥10 mut/Mb (2.6%) and HRAS (1.7%). The following alterations occurred in <1%: AKT1, KRAS G12C, BRAF V600E, BRCA, FGFR3 and IDH1. Our results highlight the relevance of CGP in identifying patients for GM or IO within clinical trials or off-label drug use. The retrospective nature of this work and the fact that FM results provided within STARTRK2 are not intended for clinical use precluded implementing these recommendations. NTRK fusions were not detected in our cohort which highlights the rarity of this event in our population." @default.
- W3207572262 created "2021-10-25" @default.
- W3207572262 creator A5006716856 @default.
- W3207572262 creator A5011120258 @default.
- W3207572262 creator A5020696914 @default.
- W3207572262 creator A5022848214 @default.
- W3207572262 creator A5023644998 @default.
- W3207572262 creator A5044371581 @default.
- W3207572262 creator A5046488539 @default.
- W3207572262 creator A5048976295 @default.
- W3207572262 creator A5049699839 @default.
- W3207572262 creator A5060791002 @default.
- W3207572262 creator A5061983852 @default.
- W3207572262 creator A5066736158 @default.
- W3207572262 creator A5068587001 @default.
- W3207572262 creator A5070242435 @default.
- W3207572262 creator A5079167064 @default.
- W3207572262 creator A5079886662 @default.
- W3207572262 creator A5080991347 @default.
- W3207572262 creator A5091332927 @default.
- W3207572262 date "2021-10-01" @default.
- W3207572262 modified "2023-10-01" @default.
- W3207572262 title "44P Value of comprehensive genomic profiling in pre-screening patients for NTRK fusion in STARTRK2 trial: Single centre experience" @default.
- W3207572262 doi "https://doi.org/10.1016/j.annonc.2021.08.2040" @default.
- W3207572262 hasPublicationYear "2021" @default.
- W3207572262 type Work @default.
- W3207572262 sameAs 3207572262 @default.
- W3207572262 citedByCount "0" @default.
- W3207572262 crossrefType "journal-article" @default.
- W3207572262 hasAuthorship W3207572262A5006716856 @default.
- W3207572262 hasAuthorship W3207572262A5011120258 @default.
- W3207572262 hasAuthorship W3207572262A5020696914 @default.
- W3207572262 hasAuthorship W3207572262A5022848214 @default.
- W3207572262 hasAuthorship W3207572262A5023644998 @default.
- W3207572262 hasAuthorship W3207572262A5044371581 @default.
- W3207572262 hasAuthorship W3207572262A5046488539 @default.
- W3207572262 hasAuthorship W3207572262A5048976295 @default.
- W3207572262 hasAuthorship W3207572262A5049699839 @default.
- W3207572262 hasAuthorship W3207572262A5060791002 @default.
- W3207572262 hasAuthorship W3207572262A5061983852 @default.
- W3207572262 hasAuthorship W3207572262A5066736158 @default.
- W3207572262 hasAuthorship W3207572262A5068587001 @default.
- W3207572262 hasAuthorship W3207572262A5070242435 @default.
- W3207572262 hasAuthorship W3207572262A5079167064 @default.
- W3207572262 hasAuthorship W3207572262A5079886662 @default.
- W3207572262 hasAuthorship W3207572262A5080991347 @default.
- W3207572262 hasAuthorship W3207572262A5091332927 @default.
- W3207572262 hasBestOaLocation W32075722621 @default.
- W3207572262 hasConcept C121608353 @default.
- W3207572262 hasConcept C126322002 @default.
- W3207572262 hasConcept C143998085 @default.
- W3207572262 hasConcept C2775999482 @default.
- W3207572262 hasConcept C2776232967 @default.
- W3207572262 hasConcept C2776256026 @default.
- W3207572262 hasConcept C2779422266 @default.
- W3207572262 hasConcept C2781182431 @default.
- W3207572262 hasConcept C2781187634 @default.
- W3207572262 hasConcept C526805850 @default.
- W3207572262 hasConcept C535046627 @default.
- W3207572262 hasConcept C71924100 @default.
- W3207572262 hasConceptScore W3207572262C121608353 @default.
- W3207572262 hasConceptScore W3207572262C126322002 @default.
- W3207572262 hasConceptScore W3207572262C143998085 @default.
- W3207572262 hasConceptScore W3207572262C2775999482 @default.
- W3207572262 hasConceptScore W3207572262C2776232967 @default.
- W3207572262 hasConceptScore W3207572262C2776256026 @default.
- W3207572262 hasConceptScore W3207572262C2779422266 @default.
- W3207572262 hasConceptScore W3207572262C2781182431 @default.
- W3207572262 hasConceptScore W3207572262C2781187634 @default.
- W3207572262 hasConceptScore W3207572262C526805850 @default.
- W3207572262 hasConceptScore W3207572262C535046627 @default.
- W3207572262 hasConceptScore W3207572262C71924100 @default.
- W3207572262 hasLocation W32075722621 @default.
- W3207572262 hasOpenAccess W3207572262 @default.
- W3207572262 hasPrimaryLocation W32075722621 @default.
- W3207572262 hasRelatedWork W2249984922 @default.
- W3207572262 hasRelatedWork W2297501306 @default.
- W3207572262 hasRelatedWork W2532138852 @default.
- W3207572262 hasRelatedWork W254943345 @default.
- W3207572262 hasRelatedWork W2569683651 @default.
- W3207572262 hasRelatedWork W2570677321 @default.
- W3207572262 hasRelatedWork W2592243930 @default.
- W3207572262 hasRelatedWork W2763698474 @default.
- W3207572262 hasRelatedWork W2846588575 @default.
- W3207572262 hasRelatedWork W2897375565 @default.
- W3207572262 hasVolume "32" @default.
- W3207572262 isParatext "false" @default.
- W3207572262 isRetracted "false" @default.
- W3207572262 magId "3207572262" @default.
- W3207572262 workType "article" @default.